Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases

Myasthenia gravis (MG) is a rare, treatable, antibody-mediated disease characterized by fatigable muscle weakness of extraocular muscles (EOMs) and non-ocular skeletal muscles. The antibodies are directed against muscle-endplate proteins, most frequently the acetylcholine receptor (AChR) alpha-subun...

Descripción completa

Detalles Bibliográficos
Autores principales: Europa, Tarin A., Nel, Melissa, Lebeko, Maribanyana R., Heckmann, Jeannine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles from the Special Issue on Neuroscience in Africa; Edited by James O. Olopade
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210483/
https://www.ncbi.nlm.nih.gov/pubmed/35746973
http://dx.doi.org/10.1016/j.ibneur.2022.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210483/
https://www.ncbi.nlm.nih.gov/pubmed/35746973
http://dx.doi.org/10.1016/j.ibneur.2022.04.007

Ejemplares similares